Beyond statins, one drug lowered heart attack risk by 20%
A PCSK9 inhibitor trims heart‑attack risk by 20 % in routine practice
Evidence dossier
Intelligence passport
Measured timeline
Coverage (9)
-
Amgen Real-World Study Links Evolocumab to Lower Heart Attack Risk Than EzetimibeBioPharm International · 1d ago
-
Evolocumab prevents more heart attacks than ezetimibe in head-to-head comparisonCardiovascular Business · 1d ago
-
-
Amgen’s Repatha reduces heart attack risk in real-world studyClinical Trials Arena · 1d ago
-
-
Evolocumab Tied to 20% Lower Risk of Myocardial Infarction vs Ezetimibe in Real-World StudyPatient Care Online · 1d ago
-
-
Amgen’s Repatha linked to fewer heart attacksSTAT · 1d ago
-
Where it stands
- Velocity & Diffusion: Coverage exploded across 8 distinct news outlets with 9 published articles, achieving a live velocity of 6.
- Primary Driver: A PCSK9 inhibitor trims heart‑attack risk by 20 % in routine practice
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
Evolocumab, sold as Repatha, cut the incidence of myocardial infarction by roughly one‑fifth compared with ezetimibe in a large real‑world analysis. The study, cited by Yahoo and Patient Care Online, tracked patients receiving the PCSK9 inhibitor and found a 20 % relative risk reduction.
Results were released by Amgen and echoed by STAT.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (60% supported) Updated 3h ago.
Answered
Which medication showed a 20% lower risk of heart attacks?
Evolocumab, marketed under the brand name Repatha, was reported to reduce heart‑attack risk by about 20 %.
What drug was used as the control in the analysis?
The study compared Repatha against ezetimibe.
What limitation does the coverage highlight about the study?
Coverage notes that the results come from a real‑world observational study focused on ezetimibe comparison, not a randomized trial, and therefore broader applicability remains uncertain.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
Related trends
Women's sex drive treatment linked to higher rates of heart attack and stroke
Women's sex drive treatment linked to higher rates of heart attack and stroke
Richard Norton, actor and martial artist, died after peptides triggered heart attack, coroner says
Actor's death linked to peptides triggers review of treatment.
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
Amgen says drug combo cuts risk of death by 58% in lung cancer patients
Conjoined Twin Influencers José Luis and José Armando Cevallos Dead After Heart Attack
Conjoined twin influencers José Luis and José Armando Cevallos, 27, die together after a sudden heart attack sparks worldwide attention.
Nana Patekar's Cause Of Death Revealed, Autopsy Report Confirms Heart Attack
Nana Patekar's cause of death confirmed as heart attack
This leg condition that’s overlooked in women can raise heart attack, stroke risk
Women at risk of heart attack and stroke due to overlooked leg condition
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.